Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

TheMotleyFool's profile

Blog
The Stock Market Just Did Something It Hasn't Done Since 2000 -- and It's Terrifying: https://g.foolcdn.com/editorial/images/849050/quant-at-desk-1.jpeg
The Stock Market Just Did Something It Hasn't Done Since 2000 -- and It's Terrifying

Since mid-October 2022, when the S&P 500 (SNPINDEX: ^GSPC) closed below $3,600, the stock market has been on an aggressive bull run. So aggressive has been the rally, so resilient and unfazed by any

You Can Do Better Than SpaceX Right Now. Here Are 2 Stocks to Buy Instead.: https://g.foolcdn.com/editorial/images/876407/gettyimages-2174673949-1200x800-5b2df79.jpg
You Can Do Better Than SpaceX Right Now. Here Are 2 Stocks to Buy Instead.

I am a huge fan of SpaceX (NASDAQ: SPCX) as a business. The company has an incredible track record of lowering the cost of launching payloads into space. And SpaceX's biggest growth initiatives --

What This $398,000 Liquidity Services Insider Sale Might Mean for Investors After a 65% Stock Rally: https://cdn.content.foolcdn.com/images/1umn9qeh/production/782b0b9f4f412d891de6f8f7670abc6b1a621e10-1401x1251.png?w=800&q=75&fit=max&auto=format
What This $398,000 Liquidity Services Insider Sale Might Mean for Investors After a 65% Stock Rally

John Daunt, EVP, Chief Commercial Officer at Liquidity Services (NASDAQ:LQDT), reported an indirect sale of 10,139 shares of Common Stock for a total value of approximately $398,000 on June 24

Relay Therapeutics Insider Sale Tops $3 Million as Shares Surge 500% This Past Year: https://cdn.content.foolcdn.com/images/1umn9qeh/production/5a835a403d8e07011d119675ff444b39fb510d2f-1401x1251.png?w=800&q=75&fit=max&auto=format
Relay Therapeutics Insider Sale Tops $3 Million as Shares Surge 500% This Past Year

On June 22, 2026, Relay Therapeutics (NASDAQ:RLAY) Chief Financial Officer Thomas Catinazzo executed an option exercise followed by the sale of 187,163 shares of Common Stock, as reported in the SEC

Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?: https://cdn.content.foolcdn.com/images/1umn9qeh/production/1a599f395be31e2f508c3aa7decb988f9ce983b7-1401x1251.png?w=800&q=75&fit=max&auto=format
Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?

On June 23, 2026, Stacy Markel, Chief People Officer at Nuvation Bio Inc. (NYSE:NUVB), exercised 125,000 options for Class A Common Stock and sold the resulting shares for a transaction value of